MSP-RON signaling is considered to be a marker of liver inflammation [82], and its hyperactivity was detected in our analysis, suggesting it plays an important role in mediating the reversal of NAFLD-associated pathologies. This evidence concerns the gene MST1 and metabolic dysfunction-associated steatotic liver disease.